BetterLife Pharma (BETRF) Interest Coverage Ratio (2015 - 2019)
BetterLife Pharma (BETRF) posted Interest Coverage Ratio of 6.93 for Q2 2019, down 602.84% on a QoQ basis from 0.99 in Q4 2018, and up 67.59% year-over-year from 4.13 in Q2 2018.
Analysis
BetterLife Pharma (BETRF) Interest Coverage Ratio (2015 - 2019) Analysis & Trends
BetterLife Pharma has reported Interest Coverage Ratio for 5 years, with the latest figure at 6.93 in Q2 2019.
- On a quarterly basis, Interest Coverage Ratio rose 67.59% year-over-year to 6.93 in Q2 2019; TTM through Apr 2019 was 2.36, a 27.67% decrease from a year earlier, with the FY2026 full-year figure at 10.41, down 65.62% from the prior year.
- Interest Coverage Ratio was 6.93 for Q2 2019 at BetterLife Pharma, down from 0.99 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.45 in Q4 2015, with the low at 191.11 in Q4 2016.
- Average Interest Coverage Ratio over 5 years is 36.4, with a median of 12.18 recorded in 2018.
- The sharpest annual moves came in 2016 and 2018: Interest Coverage Ratio sank 42886.76% in 2016, then jumped 100.41% in 2018.
- Over 5 years, Interest Coverage Ratio stood at 0.45 in 2015, then tumbled by 42886.76% to 191.11 in 2016, then jumped by 84.44% to 29.74 in 2017, then jumped by 96.68% to 0.99 in 2018, then sank by 602.84% to 6.93 in 2019.
- The last three Interest Coverage Ratio figures came in at 6.93 (Q2 2019), 0.99 (Q4 2018), and 12.18 (Q3 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | BetterLife Pharma | 31.61 Mn | 31.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2019 | -6.93 |
| Oct 31, 2018 | -0.99 |
| Jul 31, 2018 | -12.18 |
| Apr 30, 2018 | -21.38 |
| Jan 31, 2018 | 0.42 |
| Jul 31, 2017 | -29.74 |
| Apr 30, 2017 | -32.49 |
| Jan 31, 2017 | -102.14 |
| Oct 31, 2016 | -191.11 |
| Oct 31, 2015 | 0.45 |
| Apr 30, 2015 | -4.26 |